TTOO stock icon

T2 Biosystems
TTOO

$5.58
3.79%

Market Cap: 95.2M

 

About: T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

Employees: 113

0
Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

1.87% less ownership

Funds ownership: 5.39% [Q4 2023] → 3.51% (-1.87%) [Q1 2024]

14% less funds holding

Funds holding: 21 [Q4 2023] → 18 (-3) [Q1 2024]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

62% less capital invested

Capital invested by funds: $1.37M [Q4 2023] → $520K (-$848K) [Q1 2024]

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$3
46%
downside
Avg. target
$3
46%
downside
High target
$3
46%
downside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Canaccord Genuity
Kyle Mikson
46%downside
$3
Hold
Maintained
29 Apr 2024

Financial journalist opinion